JPY 2393.0
(0.46%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 189.52 Billion JPY | 7.04% |
2022 | 177.05 Billion JPY | -4.14% |
2021 | 184.71 Billion JPY | 79.51% |
2020 | 102.89 Billion JPY | -3.12% |
2019 | 106.2 Billion JPY | 14.99% |
2018 | 92.36 Billion JPY | 0.1% |
2017 | 92.26 Billion JPY | -4.31% |
2016 | 96.42 Billion JPY | -8.96% |
2015 | 105.9 Billion JPY | -6.91% |
2014 | 113.76 Billion JPY | -8.14% |
2013 | 123.84 Billion JPY | 0.32% |
2012 | 123.44 Billion JPY | 3.87% |
2011 | 118.85 Billion JPY | -21.22% |
2010 | 150.87 Billion JPY | -2.62% |
2009 | 154.92 Billion JPY | -0.67% |
2008 | 155.97 Billion JPY | 13.58% |
2007 | 137.32 Billion JPY | 1.88% |
2006 | 134.78 Billion JPY | 6.23% |
2005 | 126.89 Billion JPY | -7.78% |
2004 | 137.59 Billion JPY | 2.17% |
2003 | 134.66 Billion JPY | -9.18% |
2002 | 148.27 Billion JPY | -31.68% |
2001 | 217.01 Billion JPY | -7.4% |
2000 | 234.35 Billion JPY | -0.24% |
1999 | 234.91 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 207.32 Billion JPY | -6.58% |
2024 Q3 | 206.71 Billion JPY | -0.29% |
2024 Q1 | 221.91 Billion JPY | 17.09% |
2023 FY | 189.52 Billion JPY | 7.04% |
2023 Q1 | 163.85 Billion JPY | -7.46% |
2023 Q3 | 191.9 Billion JPY | 3.79% |
2023 Q2 | 184.9 Billion JPY | 12.85% |
2023 Q4 | 189.52 Billion JPY | -1.24% |
2022 Q1 | 163.36 Billion JPY | -11.56% |
2022 Q3 | 177.53 Billion JPY | 1.8% |
2022 Q4 | 177.05 Billion JPY | -0.27% |
2022 FY | 177.05 Billion JPY | -4.14% |
2022 Q2 | 174.39 Billion JPY | 6.75% |
2021 FY | 184.71 Billion JPY | 79.51% |
2021 Q1 | 101.26 Billion JPY | -1.59% |
2021 Q2 | 99.24 Billion JPY | -1.99% |
2021 Q3 | 143.53 Billion JPY | 44.63% |
2021 Q4 | 184.71 Billion JPY | 28.69% |
2020 Q2 | 93.71 Billion JPY | -6.63% |
2020 FY | 102.89 Billion JPY | -3.12% |
2020 Q4 | 102.89 Billion JPY | 7.19% |
2020 Q3 | 95.98 Billion JPY | 2.42% |
2020 Q1 | 100.37 Billion JPY | -5.49% |
2019 FY | 106.2 Billion JPY | 14.99% |
2019 Q4 | 106.2 Billion JPY | 17.72% |
2019 Q3 | 90.22 Billion JPY | -3.98% |
2019 Q2 | 93.96 Billion JPY | -17.81% |
2019 Q1 | 114.31 Billion JPY | 23.77% |
2018 FY | 92.36 Billion JPY | 0.1% |
2018 Q2 | 87.5 Billion JPY | -2.32% |
2018 Q4 | 92.36 Billion JPY | 5.74% |
2018 Q3 | 87.34 Billion JPY | -0.18% |
2018 Q1 | 89.58 Billion JPY | -2.91% |
2017 Q4 | 92.26 Billion JPY | 6.85% |
2017 FY | 92.26 Billion JPY | -4.31% |
2017 Q1 | 91.42 Billion JPY | -5.18% |
2017 Q2 | 88.71 Billion JPY | -2.96% |
2017 Q3 | 86.34 Billion JPY | -2.67% |
2016 FY | 96.42 Billion JPY | -8.96% |
2016 Q4 | 96.42 Billion JPY | 11.73% |
2016 Q1 | 97.01 Billion JPY | -8.39% |
2016 Q2 | 91.53 Billion JPY | -5.65% |
2016 Q3 | 86.29 Billion JPY | -5.72% |
2015 Q3 | 96.04 Billion JPY | -1.54% |
2015 Q4 | 105.9 Billion JPY | 10.27% |
2015 Q1 | 100.04 Billion JPY | -12.06% |
2015 Q2 | 97.54 Billion JPY | -2.5% |
2015 FY | 105.9 Billion JPY | -6.91% |
2014 Q4 | 113.76 Billion JPY | -15.4% |
2014 Q1 | 98.48 Billion JPY | -20.48% |
2014 Q3 | 134.47 Billion JPY | 51.42% |
2014 Q2 | 88.81 Billion JPY | -9.82% |
2014 FY | 113.76 Billion JPY | -8.14% |
2013 Q1 | 126.92 Billion JPY | 2.82% |
2013 FY | 123.84 Billion JPY | 0.32% |
2013 Q2 | 112.03 Billion JPY | -11.73% |
2013 Q3 | 110.91 Billion JPY | -1.0% |
2013 Q4 | 123.84 Billion JPY | 11.65% |
2012 FY | 123.44 Billion JPY | 3.87% |
2012 Q1 | 122.75 Billion JPY | 3.29% |
2012 Q2 | 118.67 Billion JPY | -3.32% |
2012 Q3 | 117.31 Billion JPY | -1.15% |
2012 Q4 | 123.44 Billion JPY | 5.23% |
2011 Q1 | 110.67 Billion JPY | -26.65% |
2011 Q3 | 109.41 Billion JPY | -9.4% |
2011 Q2 | 120.77 Billion JPY | 9.13% |
2011 FY | 118.85 Billion JPY | -21.22% |
2011 Q4 | 118.85 Billion JPY | 8.62% |
2010 Q4 | 150.87 Billion JPY | 11.73% |
2010 Q1 | 141.93 Billion JPY | 0.0% |
2010 Q2 | 139.12 Billion JPY | -1.98% |
2010 FY | 150.87 Billion JPY | -2.62% |
2010 Q3 | 135.03 Billion JPY | -2.94% |
2009 Q3 | 168.25 Billion JPY | 1.95% |
2009 FY | 154.92 Billion JPY | -0.67% |
2009 Q2 | 165.03 Billion JPY | 0.0% |
2008 FY | 155.97 Billion JPY | 13.58% |
2007 FY | 137.32 Billion JPY | 1.88% |
2006 FY | 134.78 Billion JPY | 6.23% |
2005 FY | 126.89 Billion JPY | -7.78% |
2004 FY | 137.59 Billion JPY | 2.17% |
2003 FY | 134.66 Billion JPY | -9.18% |
2002 FY | 148.27 Billion JPY | -31.68% |
2001 FY | 217.01 Billion JPY | -7.4% |
2000 FY | 234.35 Billion JPY | -0.24% |
1999 FY | 234.91 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Astellas Pharma Inc. | 1973.61 Billion JPY | 90.397% |
Chugai Pharmaceutical Co., Ltd. | 306.96 Billion JPY | 38.259% |
Ono Pharmaceutical Co., Ltd. | 115.06 Billion JPY | -64.712% |
Santen Pharmaceutical Co., Ltd. | 130.33 Billion JPY | -45.418% |
JCR Pharmaceuticals Co., Ltd. | 45.74 Billion JPY | -314.267% |
Daiichi Sankyo Company, Limited | 1763.11 Billion JPY | 89.251% |
Otsuka Holdings Co., Ltd. | 924.92 Billion JPY | 79.509% |
Perseus Proteomics Inc. | 295.46 Million JPY | -64043.976% |